DeviceTalks Podcast Network

In this episode of OlympusTalks, host Tom Salemi is joined by Dr. Davinderbir Pannu, a gastroenterologist practicing at McLeod Health in South Carolina, and Amanda Call, Clinical Education Specialist at Olympus, for a conversation on how endoscopic imaging advancements support clinical decision-making during screening and therapeutic procedures. Together, they discuss real-world experiences using the EVIS X1™ endoscopy system and Extended Depth of Field (EDOF™) technology, with a focus on visualization, clinical efficiencies, and procedural confidence in both routine and advanced GI cases. 

Chapter 1: Meet the Guests 

Dr. Davinderbir Pannu discusses his career path into gastroenterology and advanced endoscopic procedures, including his current clinical practice. 

Amanda Call shares her background as a registered nurse and her transition into clinical endoscopy support at Olympus. 

Chapter 2: Clinical Challenges in GI Endoscopy 

The importance of visualization in screening colonoscopy and advanced therapeutic procedures.  

Common challenges related to movement, anatomy, and image clarity during endoscopic exams. 

Chapter 3: Imaging Technologies in Practice 

Overview of the EVIS X1™ endoscopy system, including TXI™ and RDI™ technologies. 

How EDOF technology supports visualization during procedures.  

Chapter 4: Supporting Screening and Therapeutic Procedures 

Detecting flat and serrated polyps during screening exams. 

Using imaging enhancements during procedures such as EMR, ESD, and third-space endoscopy. 

Visualization considerations in inflammatory bowel disease and other GI conditions.  

Chapter 5: Workflow, Ergonomics, and the Support Team 

Ergonomic design considerations, including scope weight and button access. 

Communicating scope and equipment needs across the endoscopy team to support efficient workflows.  

For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts. 
 
This podcast has been paid for by Olympus Corporation of the Americas. The views and experiences shared are those of Dr. Davinderbir Pannu, a paid consultant of Olympus Corporation and its affiliates. Olympus makes no representations regarding the accuracy or applicability of the content and disclaims all liability arising from its use. Product performance may vary, and techniques, instruments, and clinical decisions are unique to each facility and practitioner. Always refer to the Instructions for Use (IFU) and applicable labeling for guidance, risks, and cautions. 

ADDITIONAL RESOURCES: 
 
Bring more into focus. Discover EDOF technology and how it may support your clinical practice: https://info.olympusamericamarketing.com/edof-technology

Chapters

(00:00:00) - Meet the Guests
(00:09:03) - Clinical Challenges in GI Endoscopy
(00:16:04) - Imaging Technologies in Practice
(00:20:05) - Supporting Screening and Therapeutic Procedures
(00:21:11) - Workflow, Ergonomics, and the Support Team

In this episode, the editorial team shares their highlights and lessons from two great days at DeviceTalks Boston.

Tom Salemi, Kayleen Brown, Chris Newmarker, Jim Hammerand, Sean Whooley and Skyler Rivera highlighted discussions on new technologies, personal stories, Boston’s ecosystem, and the power of MedTech. Joining them on the panel were special guests Saul Marquez of the Outcomes Rocket, Etienne Nichols of Greenlight Guru and Holly Scott of The Mullings Group. 

3:51 – Happy Birthday Kayleen Brown!

5:13 – MassDevice Executive Editor Chris Newmarker – Power of the Personal Story

9:25 - Senior Editor Sean Whooley – Analyzing Boston’s exceptionalism

11:10 -Associate Editor Skyler Rivera – Women in MedTech breakfast

14:05 – DeviceTalks Managing Editor Kayleen Brown -Designing for Reality/ Flipping the Script

17:28 - MDO Managing Editor Jim Hammerand – News Team Assembled!

20:10 – Saul Marquez, Outcomes Rocket – Importance of Conferences

24:16 – Etienne Nichols, Greenlight Guru – Why Making a Difference Matters

28:22 – Holly Scott, Senior Partner, The Mullings Group – Serendipity and MedTech Innovators

32:10 – Tom Salem – We Must Pay it Forward, New MedTech modalities

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:03:51) - Happy Birthday Kayleen Brown
(00:05:13) - – MassDevice Executive Editor Chris Newmarker – Power of the Personal Story
(00:09:25) - Senior Editor Sean Whooley – Analyzing Boston’s exceptionalism
(00:11:10) - Associate Editor Skyler Rivera – Women in MedTech breakfast
(00:14:05) - DeviceTalks Managing Editor Kayleen Brown -Designing for Reality/ Flipping the Script
(00:17:28) - MDO Managing Editor Jim Hammerand – News Team Assembled!
(00:20:10) - Saul Marquez, Outcomes Rocket – Importance of Conferences/Christian Howell
(00:24:16) - Etienne Nichols, Greenlight Guru – Why Making a Difference Matters
(00:28:22) - Holly Scott, Senior Partner, The Mullings Group – Serendipity and MedTech Innovators
(00:32:10) - Tom Salemi - Pay It Forward, New MedTech Modalities

In this episode of DeviceTalks Weekly, Host Tom Salemi speaks with Axoft CEO and co-founder Paul Le Floch about the future of brain-computer interfaces and the material science breakthroughs powering the next generation of neural implants.

Le Floch shares how his background in materials science led to the development of “Fleuron,” Axoft’s soft, flexible implant material designed to better match the brain’s delicate tissue and reduce long-term damage caused by traditional rigid implants. The conversation explores the challenges facing the BCI industry, including device durability, signal stability, and the difficulty of commercializing implantable neurotechnology. Le Floch also discusses Axoft’s focus on treating disorders of consciousness, its collaboration with Mass General Hospital, the company’s recent $55 million Series A financing, and why Massachusetts remains both an ideal — and expensive — place to build a deep-tech MedTech startup.

 In our FOMO Studio, Salemi sits down with MassMEDIC President Brian Johnson and Holly Scott of The Mullings Group to preview DeviceTalks Boston and explore the state of the Massachusetts MedTech ecosystem. Johnson reflects on MassMEDIC’s 30th anniversary, the evolution of DeviceTalks, and why Massachusetts remains one of the world’s leading hubs for medical technology innovation. The conversation covers the region’s deep strengths in robotics, orthopedics, organ transplantation, and cardiovascular technology, along with the challenges startups face in securing early-stage funding and navigating tariffs and manufacturing shifts.

And of course we start of with MassDevice Editor Chris Newmarker's top news from the pages of MassDevice - Cagent Vascular, BD, Medtronic, Johnson & Johnson MedTech, Endologix, Surmodics and Boston Scientific.

Join us May 27-28th at DeviceTalks Boston. Visit Boston.DeviceTalks.com for the full agenda and speakers. 

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:04:41) - Cagent Vascular reports first-in-human IVL cases, closes $41M Series D
(00:06:31) - BD taps former J&J leader as new president of Interventional
(00:10:09) - Endologix acquires Pounce thrombectomy system from Surmodics
(00:11:32) - Medtronic to acquire peripheral nerve stim developer SPR Therapeutics
(00:13:30) - Boston Scientific invests $1.5B in TAVR developer MiRus, enters $2B share repurchase agreement

In this special episode of the DeviceTalks Women in MedTech podcast, Host Kayleen Brown brings listeners inside the 6th Women in MedTech Breakfast held May 4 at DeviceTalks Minnesota for a powerful keynote panel on “The Art of High-Stakes Decision-Making.”

The conversation features Cat Jennings, SVP and President of Vascular Therapies at Boston Scientific; Laura Stoltenberg, President and CEO of Cryosa; and Marcie DeWalt, Chief Human Resources Officer at Provation. Together, they explore what it really takes to lead through uncertainty. From billion-dollar M&A and clinical trial bets to organizational transformations and personal career pivots, the panelists share candid stories about navigating moments where the pressure is real and the outcomes are uncertain.

Throughout the discussion, the leaders examine the balance between data and intuition, the importance of stakeholder alignment, and how to develop the conviction to move forward when there is no "undo" button. Whether managing portfolio strategy at a strategic or navigating the growth of a startup, this episode offers practical frameworks for making decisions that shape companies, careers, and patient care.

Kayleen also welcomes Heather Hudnut Page and Archana Desai in-studio to discuss the inspiration behind this year’s theme and how the Women in MedTech Breakfast continues creating space for authentic leadership conversations and community-building across the industry.

Thank you to Aptyx for sponsoring the Women in MedTech Breakfast at DeviceTalks Minnesota and supporting these essential industry conversations!! Visit https://www.aptyx.com to learn more.

Join us May 27-28th at DeviceTalks Boston for the next Women in MedTech Breakfast featuring Dr. Carla Goulart Peron, Chief Medical Officer for Philips to discuss designing MedTech for reality. https://boston.devicetalks.com/

***

Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:00:00) - Intro + DeviceTalks Boston 2026 preview
(00:04:07) - In-studio guests: Heather Hudnut Page and Archana Desai
(00:22:53) - Kayleen on Artemis II & High-Stakes Decision Making
(00:25:40) - Keynote Panel: Cat Jennings, Laura Stoltenberg, and Marcie DeWalt
(00:33:30) - M&A, Reorganizations, and Tough Business Decisions
(00:50:00) - Clinical Trial Risks, Innovation Bets, and Portfolio Strategy
(01:01:25) - Final Leadership Lessons: How Great Leaders Make High-Stakes Decisions
(01:05:03) - Closing Remarks and Thank You to Aptyx

In this special DeviceTalks Weekly Podcast episode, Host Tom Salemi previews the biggest conversations, technologies, and innovators heading to DeviceTalks Boston on May 27–28 at the Boston Convention & Exhibition Center.

First, Tom Salemi and Mike Moore, partner at The Mullings Group, visits with Christian Howell, CEO of Cognito Therapeutics. Howell will be speaking at DeviceTalks Boston about the neuro company’s clinical, fund-raising and partnering success.

Howell also shares insights into Cognito’s partnerships with research institutions and the future of noninvasive therapies for neurodegenerative disease. He’ll be among the many speakers address Innovation & Investment at the conference, with others including the MedTech Innovator Open Rounds sessions and venture capital investors including Abby Hunter-Syed of Olympus Innovation Ventures and Maria Berkman, MD, of Vensana Capital.

Tom and Holly Scott also speak with Dr. Sarah Matt, author of Borderless Healthcare Revolution, about the challenges of connected health adoption and why many health-tech pilots fail to scale. Matt previews her DeviceTalks Boston panel examining the “physician veto” and the barriers device makers face when introducing new digital health technologies into clinical environments.

Several sessions at DeviceTalks Boston will address the challenges and opportunities of Connected Health including a keynote interview with Ashley McEvoy, CEO of Insulet, as well as presentations by Philips, Baxter and others.

The episode also features a wide-ranging conversation with Mullings Group leaders Mike Moore and Holly Scott about the strength of the Massachusetts medtech ecosystem, the growth of surgical robotics, and the importance of conferences in building meaningful industry relationships.

If you want to join us at DeviceTalks Boston, you can register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the price of registration.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:03:40) - Mike Moore of The Mulling Group and Tom interview Christian Howell, CEO of Cognito Therapeutics
(00:15:40) - Holly Scott of the Mullings Group and Tom interview Sarah Matt, MD, author of The Borderless Healthcare Revolution
(00:22:30) - Holly, Mike and Tom breakdown the components of DeviceTalks Boston and the Massachusetts MedTech industry